The healthcare industry has been relying on traditional research approaches for a long time, but the information gained from these methods often needs to be expanded in scope.
Real-world evidence studies have the potential to provide new insights into clinical interventions and patient outcomes, giving us a clearer understanding of what works best in different scenarios. Read on to find out why This type of research is essential for making informed decisions in the healthcare sector.
There are several benefits of conducting Real-World Evidence (RWE) studies. RWE can provide insights complementary to traditional clinical trials and help generate new hypotheses about the safety and efficacy of treatments. RWE studies can also be conducted at a fraction of the cost and time of clinical trials, making them an attractive option for drug developers.
There are many challenges associated with conducting real-world evidence studies. First, it can be difficult to identify and enroll appropriate study participants. Second, data collected in the real world is often of lower quality than data collected in controlled clinical trials. It can make it difficult to draw reliable conclusions from real-world evidence studies. Third, real-world evidence studies are often conducted on small samples of patients, which can limit their statistical power and generalizability. Finally, the results of real-world evidence studies can be confounded by numerous factors, such as patients’ baseline characteristics, concomitant medications, and health status at the time of data collection.